We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Lipid Levels and Estrogen Replacement Therapy in Postmenopausal Women

Moshe S. Weintraub, MD; Itamar Grosskopf, MD
Arch Intern Med. 1999;159(9):1014. doi:.
Text Size: A A A
Published online


In reply

In reply to the letter of Drs Ness and Pan regarding our article,1 I should like to make the following comments.

We agree that the most recent results of the HERS2 are of great importance. Yet, as Ness and Pan themselves pointed out, that study, however well designed and executed, cannot outrightly refute the present policy of giving hormonal replacement therapy (HRT) to postmenopausal women to achieve, among other goals, a significant decrease (30%-50%) in coronary artery disease. It should be noted that HERS is a secondary prevention study with a follow-up period of only 4 years and that it was carried out in a population largely (50%) already treated with hypolipidemic medications. These drugs are probably more effective in reducing low-density lipoprotein–cholesterol than is HRT in postmenopausal women, and they could mask the true effect of HRT. The consequences of HRT on a woman's biological system are probably more pronounced when treatment is begun shortly after menopause. Therefore, HRT should not be expected to have the same dramatic effect when started after 18 years of hypogonadism, a time when atherosclerosis in many individuals is already advanced.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles